TY - JOUR T1 - Fast initial Covid-19 response means greater caution may be needed later JF - medRxiv DO - 10.1101/2020.05.26.20112680 SP - 2020.05.26.20112680 AU - Joël J.-M. Hirschi Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/27/2020.05.26.20112680.abstract N2 - Background As the Covid-19 pandemic unfolds it is becoming increasingly clear that the strength of the first wave of the epidemic varies significantly between countries. In this study a simple numerical model is used to illustrate the impact the timing of initial measures against Covid-19 has on the first wave of infection and possible implications this may have for the measures taken as the first wave is ebbing. The results highlight that delaying measures by 10 days is sufficient to largely account for the differences seen between countries such as the UK and Germany for the first wave of infections. A pronounced first wave means that a larger fraction of the total population will have been infected and is therefore likely to display immunity. Even if this fraction is far below the level needed for “herd immunity” the effective reproduction factor Re is decreased compared to a population that had no prior exposure to the virus. Even a small reduction in Re can have major influence on the evolution of the epidemic after the first wave of infections. A large first wave means the resulting value for Re will be lower than if the first wave was mild. Without either vaccine or effective treatment countries that experienced a small first wave should therefore relax measures at a slower pace than countries where the first wave was strong.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency, commercial or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research does not require approval of the IRB/oversight body as it did not involve any human subjects (or animals). This is a numerical modelling study and results are compared against freely available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study are freely available from Worldometers.com ER -